These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3663955)

  • 1. Urinary androgens and tumor estrogen receptor as predictors of ovariectomy response and of survival in advanced breast cancer.
    Oriana S; Secreto G; Di Fronzo G; Torri A
    Breast Cancer Res Treat; 1987; 9(3):201-5. PubMed ID: 3663955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission after ovariectomy for advanced breast cancer correlated with estrogen receptor status and urinary androgen excretion.
    Oriana S; Secreto G; Di Fronzo G; Böhm S; Torri A
    Breast Cancer Res Treat; 1988 Dec; 12(3):303-5. PubMed ID: 3228592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation of estrogen receptors and urinary androgens in ovariectomy for advanced breast cancer.
    Oriana S; Scavone G; Böhm S; Di Fronzo G; Preda F
    Tumori; 1984 Apr; 70(2):185-7. PubMed ID: 6730017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion.
    Oriana S; Secreto G; Severini A; Di Fronzo G; Di Giuseppe M; Valagussa P; Preda F
    Breast Cancer Res Treat; 1982; 2(1):101-4. PubMed ID: 7171833
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical response and survival according to estrogen receptor levels after bilateral ovariectomy in advanced breast cancer.
    Oriana S; Böhm S; Baeli A; Scavone G; Riboldi G; Torri A
    Eur J Surg Oncol; 1989 Feb; 15(1):39-42. PubMed ID: 2917664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between estrogen receptor levels and clinical response to ovariectomy in premenopausal women with advanced breast cancer.
    Oriana S; Riboldi GL; Böhm S; Baeli A; Sasso GM; Oriana V
    Eur J Surg Oncol; 1986 Dec; 12(4):343-6. PubMed ID: 3536581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
    Rivkin SE; Green S; O'Sullivan J; Cruz AB; Abeloff MD; Jewell WR; Costanzi JJ; Farrar WB; Osborne CK
    J Clin Oncol; 1996 Jan; 14(1):46-51. PubMed ID: 8558219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic oophorectomy in metastatic breast cancer.
    Conte CC; Nemoto T; Rosner D; Dao TL
    Cancer; 1989 Jul; 64(1):150-3. PubMed ID: 2731111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between clinical response to bilateral oophorectomy, estrogen receptors and urinary androgen excretion in 49 patients with advanced breast cancer.
    Preda F; Pizzocaro G; Oriana S; Riboldi G; Severini A; Di Fronzo G; Secreto G; Grattarola R
    Tumori; 1979 Jun; 65(3):325-30. PubMed ID: 462582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study.
    Falkson G; Holcroft C; Gelman RS; Tormey DC; Wolter JM; Cummings FJ
    J Clin Oncol; 1995 Jun; 13(6):1453-8. PubMed ID: 7751892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol receptor activity in human breast cancer, disease free interval and survival time.
    Heise E; Görlich M
    Anticancer Res; 1982; 2(1-2):33-6. PubMed ID: 7114801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.
    Taylor CW; Green S; Dalton WS; Martino S; Rector D; Ingle JN; Robert NJ; Budd GT; Paradelo JC; Natale RB; Bearden JD; Mailliard JA; Osborne CK
    J Clin Oncol; 1998 Mar; 16(3):994-9. PubMed ID: 9508182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-hormone receptors in breast cancer.
    Wittliff JL
    Cancer; 1984 Feb; 53(3 Suppl):630-43. PubMed ID: 6692266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients.
    Nomura Y; Yamagata J; Kondo H
    Gan; 1979 Aug; 70(4):473-82. PubMed ID: 510847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
    Swain SM; Wilson JW; Mamounas EP; Bryant J; Wickerham DL; Fisher B; Paik S; Wolmark N
    J Natl Cancer Inst; 2004 Apr; 96(7):516-23. PubMed ID: 15069113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.